FDA draft guidelines suggest route to approval for early-stage Alzheimer’s drugs
By
McKnight's Staff
Feb 11, 2013
The Food and Drug Administration issued draft guidance Thursday on clinical trials for early-stage Alzheimer’s drugs.
Study: New test might help diagnose Alzheimer’s earlier
Jun 24, 2011
A new test that measures amyloid levels in the spinal fluid of people with mild cognitive impairment could help physicians more accurately predict who will develop Alzheimer’s, a new study finds.